ArticleMarine drugs2015

Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.

Ion Cristóbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.